Schuchart Aaron Insider Trades

Insider Trading History

Track insider trading activity for Schuchart Aaron. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $52.1k 12,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.8k 13,000 shares
$3.52
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $23.4k 5,381 shares
Last Trade
Feb 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$366 104 shares
$3.52
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $17.3k 3,985 shares
Last Trade
Feb 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$521 52 shares
$10.02
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $52.1k 12,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 13,000 shares
$10.02
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $13.2k 3,037 shares
Last Trade
Aug 12, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.6k 1,700 shares
$7.42
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $5.8k 1,337 shares
Last Trade
Aug 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.21k 300 shares
$7.35
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $33.9k 7,805 shares
Last Trade
Jun 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.1k 7,805 shares
$10.13
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $0 0 shares
Last Trade
May 06, 2021 Sale
$408k 45,000 shares
$9.06
$4.34
Lumos Pharma
Lumos Pharma LUMO
Chief Business Officer
Holding Value $0 0 shares
Last Trade
Mar 01, 2021 Sale
$127k 8,500 shares
$14.97
$4.34
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Business Officer
Holding Value $721k 60,000 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5M 60,000 shares
$209.00
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Business Officer
Holding Value $101k 8,400 shares
Last Trade
Sep 27, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.44M 6,000 shares
$239.25
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Business Officer
Holding Value $102k 8,500 shares
Last Trade
Aug 17, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.96M 8,500 shares
$230.00
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Business Officer
Holding Value $1.1M 91,500 shares
Last Trade
Aug 17, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.96M 8,500 shares
$230.00
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Business Officer
Holding Value $240k 20,000 shares
Last Trade
Feb 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.16M 20,000 shares
$157.75
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Business Officer
Holding Value $120k 10,000 shares
Last Trade
Aug 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$775k 10,000 shares
$77.50
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Business Officer
Holding Value $1.2M 100,000 shares
Last Trade
Jun 16, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.75M 100,000 shares
$87.50
$12.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up